about
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineMarketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant TherapyZinc and cancer: implications for LIV-1 in breast cancer.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FACE: the barefaced facts of AI potency.
@ast
FACE: the barefaced facts of AI potency.
@en
FACE: the barefaced facts of AI potency.
@nl
type
label
FACE: the barefaced facts of AI potency.
@ast
FACE: the barefaced facts of AI potency.
@en
FACE: the barefaced facts of AI potency.
@nl
prefLabel
FACE: the barefaced facts of AI potency.
@ast
FACE: the barefaced facts of AI potency.
@en
FACE: the barefaced facts of AI potency.
@nl
P2860
P356
P1476
FACE: the barefaced facts of AI potency.
@en
P2093
Alain Monnier
P2860
P304
P356
10.2147/CMR.S13511
P407
P577
2010-10-27T00:00:00Z